Document Detail

Door to balloon times: streamlining admission for primary percutaneous coronary intervention.
MedLine Citation:
PMID:  20186239     Owner:  NLM     Status:  MEDLINE    
AIMS: Primary angioplasty is superior to thrombolysis in ST elevation myocardial infarction (STEMI). This advantage is dependent on how quickly angioplasty can be performed. Several strategies have been suggested to cut door to balloon (D2B) times. We aimed to audit and reorganise the admission process to accelerate D2B times, in Waikato Hospital, New Zealand. METHODS: The admission process for STEMI was audited. Three changes were made. One step in the catheterisation lab activation system (referral to cardiology registrar on call) was removed. Single call pager activation of the catheterisation lab team was adopted. Feedback of timing performance data by email and printout was established. Timing data were collected for 6 months before and after these changes. RESULTS: After the admission process was changed 88.5% of patients had a D2B time <90 min vs 63.6% before. Median D2B times were reduced from 74.5 min to 59 min (p=0.09). Median time from admission to arrival at cath lab was reduced from 50 min to 35 min (p=0.019). CONCLUSIONS: Relatively minor changes in admission process, without new resources, can lead to reductions in door to balloon times. This was achieved in a hospital with a selective PPCI policy and modest annual volume of PPCI.
Neil Swanson; Christopher Nunn; Steve Holmes; Gerry Devlin
Related Documents :
1867949 - Desirability of immediate surgical standby for coronary angioplasty.
8622299 - Long-term survival benefits of coronary artery bypass grafting and percutaneous translu...
1616379 - Emergency coronary artery bypass surgery for failed percutaneous coronary angioplasty. ...
16325819 - Efficacy of peroxisome proliferative activated receptor (ppar)-alpha ligands, fenofibra...
8293649 - Angiographic prediction of dissection followed by ischaemic complications during corona...
10160069 - Cardiogenic shock: thrombolysis or angioplasty?
17313639 - Transthoracic echocardiographic diagnosis of mobile aortic arch atherothrombosis associ...
24312159 - Cardioprotective c-kit(+) bone marrow cells attenuate apoptosis after acute myocardial ...
6223519 - Intracoronary thrombolysis in acute myocardial infarction.
Publication Detail:
Type:  Journal Article     Date:  2010-02-19
Journal Detail:
Title:  The New Zealand medical journal     Volume:  123     ISSN:  1175-8716     ISO Abbreviation:  N. Z. Med. J.     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-26     Completed Date:  2010-04-06     Revised Date:  2010-10-22    
Medline Journal Info:
Nlm Unique ID:  0401067     Medline TA:  N Z Med J     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  18-25     Citation Subset:  IM    
Cardiology Department, James Cook University Hospital, Middlesborough, TS4 3BW, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary*
Clinical Protocols*
Medical Audit
Middle Aged
Myocardial Infarction / therapy*
New Zealand
Patient Admission*
Time Factors
Comment In:
N Z Med J. 2010 Feb 19;123(1309):7-10   [PMID:  20186236 ]
N Z Med J. 2010 Mar 5;123(1310):122   [PMID:  20360789 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  NIH Consensus Development Conference Statement: Lactose Intolerance and Health.
Next Document:  Are at-risk New Zealand women receiving recommended cardiovascular preventive therapy?